Kolon TissueGene Faces Delisting In Korea On Invossa Uncertainties

Stock Market Down - Illustration
Kolon Life Shares Drop 22% On Decision To Delist Kolon TissueGene • Source: Shutterstock

More from South Korea

More from Focus On Asia